Company: KNRX
Filing Date: 2025-01-15
Form Type: F-1/A
Source: 0001493152-25-002249
Chunk: 271

Company: KNOREX LTD.
Filing Date: 2025-01-15
Form: F-1/A
Chunk 271
---
 the purpose of extending the Class B Validity Period, each Class A Ordinary Share shall entitle the holder thereof to
one vote and each Class B Ordinary Share shall entitle the holder thereof to one vote.

Class B Ordinary Shares shall be automatically
and immediately converted into an equal number of Class A Ordinary Shares upon (i) the expiration of the Class B Validity Period, and
(ii) the transfer of Class B Ordinary Shares. Class A Ordinary Shares are not convertible into Class B Ordinary Shares under any circumstances.

No Class B Ordinary Share shall be transferred
within the first two years from the date of its issuance unless prior written consent from all the Directors is obtained. Upon any transfer
of Class B Ordinary Shares, such Class B Ordinary Shares shall be converted automatically to Class A Ordinary Shares. Class B Ordinary
Shares are valid for 5 years from the date of issuance (the “Class B Validity Period”), after which the Class B Ordinary
Shares shall automatically be converted into Class A Ordinary Shares. The Class B Validity Period may be extended for periods of 3 years
(the “Extension”). Any Extension must be approved by both the holders of Class A Ordinary Shares and Class B Ordinary Shares
by way of an ordinary resolution.

In March 2023, the Company completed its equity
financing through the issuance of 815,050 Class A Ordinary Shares for approximately US$3.7 million and converted approximately US$8.0
million into 2,553,700 Class A Ordinary Shares from its convertible notes.

In November 2023, the Company completed additional
equity financing through the issuance of 999,025 Class A Ordinary Shares for approximately US$4.5 million. Further, a total of 317,250
warrants were exercised to subscribe for the Company’s ordinary shares for a total consideration of approximately US$0.5 million.

On February 26, 2024, the Company amended its
authorized share capital from US$50,000 divided into 5,000,000 ordinary shares of par value US$0.01 each, to US$50,000 divided into 100,000,000
ordinary shares of par value US$0.0005 each of a single class. On September 25, 2024, the authorized share capital of our Company was
further amended to US$50,000 divided into 100,000,000 ordinary shares of par value US$0.0005 each, comprising 90,000,000 Class